The convergence of synthetic biology with artificial intelligence (AI) and automation is accelerating the pace of innovation, improving accessibility and enabling more complex applications. But how is this convergence taking place today and where is it heading? How can policymakers implement agile and anticipatory governance that steer its development towards socially desirable outcomes? And where should the OECD focus its future efforts in this domain?
A new OECD policy paper “Synthetic biology, AI and automation: A forward-looking technology assessment” has laid out a series of concrete cases where these technologies are coming together and how they could develop in the future. This strategic intelligence lays the groundwork for an analysis on the policy and governance implications (from biosecurity to data supply chains to technology security) and accompanying policy options.
This webinar will present high-level takeaways from this work by the OECD Secretariat, with invited guests – from academia and tech companies as well as policymakers – providing lightning interventions on the developments in their fields. The audience will have a chance to ask questions and participate in a discussion to understand the current state of the convergence and where future action is needed most.
